APA (7th ed.) Citation

A, M., J, Y., N, S., Y, C., TG, K., R, T., . . . J, K. (2023). Efficacy of checkpoint inhibition after CAR-T failure in aggressive B-cell lymphomas: Outcomes from 15 US institutions. Blood advances, 7(16), 4528. https://doi.org/10.1182/bloodadvances.2023010016

Chicago Style (17th ed.) Citation

A, Major, et al. "Efficacy of Checkpoint Inhibition After CAR-T Failure in Aggressive B-cell Lymphomas: Outcomes from 15 US Institutions." Blood Advances 7, no. 16 (2023): 4528. https://doi.org/10.1182/bloodadvances.2023010016.

MLA (9th ed.) Citation

A, Major, et al. "Efficacy of Checkpoint Inhibition After CAR-T Failure in Aggressive B-cell Lymphomas: Outcomes from 15 US Institutions." Blood Advances, vol. 7, no. 16, 2023, p. 4528, https://doi.org/10.1182/bloodadvances.2023010016.